Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). (Q41001074)

25 September 2017

Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). (English)

1 reference

25 September 2017

0 references

1 reference

Wang S

1

1 reference

25 September 2017

Guo CY

2

1 reference

25 September 2017

Castillo A

3

1 reference

25 September 2017

Dent P

4

1 reference

25 September 2017

Grant S

5

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

25 September 2017

Biochemical Pharmacology

1 reference

25 September 2017

56

1 reference

25 September 2017

5

1 reference

25 September 2017

635-644

1 reference

Update on the antitumor activity of paclitaxel in clinical trials

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Taxol: an antimitotic agent with a new mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Premature p34cdc2 activation required for apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Inactivation of Bcl-2 by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Bcl-2 phosphorylation required for anti-apoptosis function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900188-9

10.1016/S0006-2952(98)00188-9

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference